Search research articles
Contact Us
Filters
Showing results (11-20 of 23) with videos related to
Page
of 3
Sort By:
Brain Research
|
May 7, 1984
Gallamine and vagotomy enhance respiratory modulation of reticular units
D Caille, A S Foutz, J F Vibert, et al.
Journal of Neural Transmission. Supplementum
|
January 1, 1994
Biochemical pharmacology of befloxatone (MD370503), a new potent reversible MAO-A inhibitor
V Rovei, D Caille, O Curet, et al.
Neuroscience Letters
|
January 1, 1979
Ascending projection from the respiratory centre to mesencephalon and diencephalon
J F Vibert, D Caille, F Bertrand, et al.
Respiration Physiology
|
February 1, 1979
Pentobarbitone effects on respiration related units; selective depression of bulbopontine reticular neurones
D Caille, J F Vibert, F Bertrand, et al.
Diabetes, Obesity & Metabolism
|
October 9, 2007
Islet-cell-to-cell communication as basis for normal insulin secretion
S Bavamian, P Klee, A Britan, et al.
Journal of Affective Disorders
|
May 20, 1999
Preclinical profile of befloxatone, a new reversible MAO-A inhibitor
O Curet, G Damoiseau-Ovens, C Sauvage, et al.
European Journal of Pharmacology
|
March 10, 2001
Cardiovascular effects of SL65.0472, a 5-HT receptor antagonist
S E O'Connor, A Grosset, C D La Rochelle, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1996
Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile
D Caille, O E Bergis, C Fankhauser, et al.
Kidney International
|
July 12, 2007
Connexin40 regulates renin production and blood pressure
N Krattinger, A Capponi, L Mazzolai, et al.
Diabetologia
|
April 4, 2008
Functional significance of repressor element 1 silencing transcription factor (REST) target genes in pancreatic beta cells
D Martin, F Allagnat, G Chaffard, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 23) with videos related to
Sort By:
Page
of 3
Brain Research
|
May 7, 1984
Gallamine and vagotomy enhance respiratory modulation of reticular units
D Caille, A S Foutz, J F Vibert, et al.
Journal of Neural Transmission. Supplementum
|
January 1, 1994
Biochemical pharmacology of befloxatone (MD370503), a new potent reversible MAO-A inhibitor
V Rovei, D Caille, O Curet, et al.
Neuroscience Letters
|
January 1, 1979
Ascending projection from the respiratory centre to mesencephalon and diencephalon
J F Vibert, D Caille, F Bertrand, et al.
Respiration Physiology
|
February 1, 1979
Pentobarbitone effects on respiration related units; selective depression of bulbopontine reticular neurones
D Caille, J F Vibert, F Bertrand, et al.
Diabetes, Obesity & Metabolism
|
October 9, 2007
Islet-cell-to-cell communication as basis for normal insulin secretion
S Bavamian, P Klee, A Britan, et al.
Journal of Affective Disorders
|
May 20, 1999
Preclinical profile of befloxatone, a new reversible MAO-A inhibitor
O Curet, G Damoiseau-Ovens, C Sauvage, et al.
European Journal of Pharmacology
|
March 10, 2001
Cardiovascular effects of SL65.0472, a 5-HT receptor antagonist
S E O'Connor, A Grosset, C D La Rochelle, et al.
The Journal of Pharmacology and Experimental Therapeutics
|
April 1, 1996
Befloxatone, a new reversible and selective monoamine oxidase-A inhibitor. II. Pharmacological profile
D Caille, O E Bergis, C Fankhauser, et al.
Kidney International
|
July 12, 2007
Connexin40 regulates renin production and blood pressure
N Krattinger, A Capponi, L Mazzolai, et al.
Diabetologia
|
April 4, 2008
Functional significance of repressor element 1 silencing transcription factor (REST) target genes in pancreatic beta cells
D Martin, F Allagnat, G Chaffard, et al.
Page
of 3